Skip to main content
SpringerLink
Log in

Incretin Mimetics Target Novel Pathways to Treat Type 2 Diabetes

  • Published:
Pharmaceutical & Diagnostic Innovation

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table 1
Table 2

References

  1. ADA 2004 preview. Lehman Brothers Global Equity Research (2004).

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Incretin Mimetics Target Novel Pathways to Treat Type 2 Diabetes. Pharmaceutical & Diagnostic Innovation 2, 18–22 (2004). https://doi.org/10.1007/BF03262504

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03262504

Keywords

Search

Navigation